about
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating man...
Read More
5.37
0.18
(3.47%)
241.7K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Polypid Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..